A statement released earlier today by Numis about IP Group PLC (LON:IPO) maintains the target price at 263.00GBX
- Updated: September 28, 2016
Numis hold steady the price target of IP Group PLC (LON:IPO) at 263.00GBX stating a potential upside of 0.52%.
Just yesterday IP Group PLC (LON:IPO) traded 1.93% higher at 173.05GBX. IP Group PLC’s 50-day moving average is 185.55GBX and its 200-day moving average is 168.19GBX. The last stock price is up 3.58% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. 72,663 shares of IPO traded hands, down from an average trading volume of 380,195
Recent Performance Chart
IP Group PLC has 52 week low of 117.70GBX and a 52 week high of 245.60GBX and has a market capitalization of 0 GBX.
In addition to Numis reporting its stock price target, a total of 2 brokerages have issued a research note on the company. The average stock price target is 284.50GBX with 2 brokerages rating the stock a strong buy, 0 brokerages rating the stock a buy, 0 brokerages rating the stock a hold, 0 brokerages rating the stock a underperform, and finally 0 brokerages rating the stock a sell.
Brief Synopsis On IP Group PLC (LON:IPO)
IP Group plc (IP Group) is a United Kingdom-based intellectual property commercialization company. The Company develops intellectual property-based businesses. The Company operates through three business segments: University partnership business, Venture capital fund management and In-licensing activity. The Company's University partnership business segment is engaged in the commercialization of intellectual property through the formation of long-term partner relationships with universities. The Company's Venture capital fund management segment is engaged in the management of venture funds focusing on the United Kingdom's early stage technology companies. The Company's In-licensing activity segment is engaged in the in-licensing of drugable intellectual property from research institutions. The Company's portfolio includes holdings in approximately 90 early stage businesses across over four main sectors, which include biotech, cleantech, healthcare and technology.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.